TOI Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.540.0% YoY
Profit margin-12.1%HEALTHCARE
Market cap$400.3MSmall cap

Wall Street coverage

$7.00median target· current $0.94 (+644.1%)4 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
PEG ratio
P/B
0.76
P/S (TTM)
0.80
EV/EBITDA
8.53

Profitability & growth

ROE (TTM)
-652.0%
Operating margin
-4.9%
Revenue growth YoY
41.6%
Dividend yield
Beta
0.36
Last earnings
Mar 5, 2026 · Estimate $-0.09 · Reported $-0.06
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Oncology Institute Inc

Oncology Institute Inc (ticker: TOI) is a pioneering healthcare organization dedicated to transforming cancer care through its extensive network of specialized clinics and innovative treatment modalities. The company prioritizes enhanced patient outcomes by leveraging state-of-the-art technologies and customized treatment plans, while also participating in clinical trials and collaborations with leading research institutions. As the need for advanced cancer therapies continues to grow, TOI is strategically positioned to leverage its robust pipeline and deep-seated oncology expertise,…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
18000 STUDEBAKER ROAD, CERRITOS, CA
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$400.3M
Shares outstanding$98.8M
52W high$4.88
52W low$2.02

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer